Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Kairos Pharma Ltd (KAPA)

Kairos Pharma Ltd (KAPA)
0.8700 x 5 0.9757 x 4
Post-market by (Cboe BZX)
0.8948 -0.0173 (-1.90%) 04/22/25 [NYSE Arca]
0.8700 x 5 0.9757 x 4
Post-market 0.8734 -0.0214 (-2.39%) 16:54 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8506
Day High
0.9426
Open 0.9400
Previous Close 0.9121 0.9121
Volume 136,700 136,700
Avg Vol 143,050 143,050
Stochastic %K 13.64% 13.64%
Weighted Alpha -65.98 -65.98
5-Day Change -0.0573 (-6.02%) -0.0573 (-6.02%)
52-Week Range 0.8506 - 4.0000 0.8506 - 4.0000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,226
  • Shares Outstanding, K 16,693
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,600 K
  • EBIT $ -1 M
  • EBITDA $ -2 M
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.18
  • Most Recent Earnings $-0.08 on 04/15/25
  • Next Earnings Date 04/03/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8506 +5.20%
on 04/22/25
Period Open: 1.0100
1.2500 -28.42%
on 04/04/25
-0.1152 (-11.41%)
since 03/21/25
3-Month
0.8506 +5.20%
on 04/22/25
Period Open: 1.6300
1.9200 -53.40%
on 02/04/25
-0.7352 (-45.10%)
since 01/22/25

Most Recent Stories

More News
CEO.CA's Inside the Boardroom: Kairos Pharma's Breakthrough Cancer Treatment & What's Next for ENV105

Toronto, Ontario--(Newsfile Corp. - March 28, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in venture stocks, shares exclusive updates with CEOs and executives from around the globe.Founded...

KAPA : 0.8948 (-1.90%)
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why

Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.

KAPA : 0.8948 (-1.90%)
SANA : 1.7300 (+8.81%)
SLXN : 0.7030 (-2.59%)
AEON : 0.4050 (+1.25%)
CRGX : 4.60 (unch)
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why

Cancer treatments, FDA breakthroughs, and other developments fueled a sharp spike in interest for these biotech players, as investors bet on promising clinical data and strategic moves.

KAPA : 0.8948 (-1.90%)
OSTX : 1.5200 (+2.01%)
AEON : 0.4050 (+1.25%)
EF Hutton Provided ‘Buy’ Rating, $9.00 PT in Kairos Pharma (NYSE American: KAPA) Research Report

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics, was featured in an EF Hutton report that initiated coverage with a...

KAPA : 0.8948 (-1.90%)
Kairos Pharma (NYSE American: KAPA) Receives ‘Buy’ Recommendation, $12.00 PT in Rodman & Renshaw Report

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics, is spotlighted today in a Rodman & Renshaw, LLC report that initiated...

KAPA : 0.8948 (-1.90%)
Kairos Pharma to Participate in The Microcap Conference in January 2025

LOS ANGELES, CA / ACCESSWIRE / December 16, 2024 / Kairos Pharma, (NYSE American:KAPA) a clinical stage biotechnology company is pleased to announce its participation in The Microcap Conference 2025, the...

KAPA : 0.8948 (-1.90%)
Kairos Pharma, Ltd. Announces Dual Listing on Upstream to Enhance Global Trading Opportunities

Kairos Pharma, Ltd. gains approval for dual listing on Upstream, enhancing global trading accessibility for investors.Quiver AI SummaryKairos Pharma, Ltd. announced the dual listing of its shares on Upstream,...

KAPA : 0.8948 (-1.90%)
Kairos Pharma Approved to Dual List on Upstream

KAPA : 0.8948 (-1.90%)
10 Stocks/Cryptos With Biggest Increases In Followers On Stocktwits Last Week

Dogecoin, SPY, Bitcoin, Ripple and Innovation Beverage were among the securities that drew retail attention last week.

MARA : 14.06 (+14.40%)
TSLA : 237.97 (+4.60%)
KAPA : 0.8948 (-1.90%)
BTCT : 3.78 (+12.84%)
SPY : 527.25 (+2.60%)
IBG : 0.7000 (+12.99%)
Kairos Pharma to Present at the LD Micro Main Event XVII

KAPA : 0.8948 (-1.90%)

Business Summary

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company. It focused on developing a diversified pipeline of cutting-edge oncology therapeutics born from structural biology to reverse cancer drug resistance and the inhibitory effects of cancer on the immune system. Kairos Pharma Ltd. is based...

See More

Key Turning Points

3rd Resistance Point 1.0334
2nd Resistance Point 0.9880
1st Resistance Point 0.9414
Last Price 0.8948
1st Support Level 0.8494
2nd Support Level 0.8040
3rd Support Level 0.7574

See More

52-Week High 4.0000
Fibonacci 61.8% 2.7969
Fibonacci 50% 2.4253
Fibonacci 38.2% 2.0537
Last Price 0.8948
52-Week Low 0.8506

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro